Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women

Inclusion Criteria: * Postmenopausal women aged 35 to 70 years * Body mass index (BMI) in the range of 18.0 to 35.0 kg/m2 and body weight greater than or equal to 50 kg * Healthy as determined by the investigator on the basis of medical history, physical examination, breast and gynecologic examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram (ECG). Exclusion Criteria: * Any clinically important active condition of gynecologic, cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease. * History or current evidence of thrombophlebitis, thromboembolic disorders, or any coagulopathies. * History of any clinically important drug allergy to conjugated estrogens (CE) or selective estrogen receptor modulators (SERMs).